# US 2025/0075183 A1 · Method for co-cultivation and directed differentiation induction of muscle satellite cells and adipose-derived stem cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0075183 A1
- Document ID: US20250075183A1
- Status: Published application
- Kind: A1
- Application number: 18/813,100
- Filed: 2024-08-23
- Published: 2025-03-06
- Earliest claimed: 2023-08-28
- Assignees: Ocean University of China; Qingdao Institute of Marine Bioresources for Nutrition & Health Innovation
- Applicants: Ocean University of China; Qingdao Institute of Marine Bioresources for Nutrition & Health Innovation
- Inventors: Changhu XUE; Hongwei ZHENG; Xuan ZHOU; Yingxin WEI; Haowen YIN
- Web page: https://patentgrep.com/patent/US20250075183A1

## CPC

- C12N 5/0659: {Satellite cells}
- C12N 5/0653: {Adipocytes; Adipose tissue}
- C12N 5/0658: {Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts}
- C12N 5/0667: {Adipose-derived stem cells [ADSC]; Adipose stromal stem cells}
- C12N 2500/38: Vitamins
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2502/1335: Skeletal muscle cells, myocytes, myoblasts, myotubes
- C12N 2502/1382: Adipose-derived stem cells [ADSC], adipose stromal stem cells
- C12N 2506/1323: from skeletal muscle cells
- C12N 2506/1384: from adipose-derived stem cells [ADSC], from adipose stromal stem cells
- C12N 2513/00: 3D culture
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A method for co-cultivation and directed differentiation induction of muscle satellite cells and adipose-derived stem cells is provided. The method includes the steps of co-cultivation and co-differentiation. The method for co-cultivation and directed differentiation induction of muscle satellite cells and adipose-derived stem cells provided by the present disclosure can allow the effective co-cultivation and co-directed differentiation induction of muscle satellite cells and adipose-derived stem cells from Larimichthys crocea, thereby providing a feasible solution for the large-scale production of high-quality cultivated meat.

## Claims

### Claim 1

A method for a co-cultivation and a directed differentiation induction of muscle satellite cells and adipose-derived stem cells, comprising the following steps:
(1) the co-cultivation: resuspending the muscle satellite cells and the adipose-derived stem cells from a Larimichthys crocea with a Larimichthys crocea stem cell complete medium, mixing, plating, and cultivating in a biochemical incubator at 26° C. to 30° C., wherein the Larimichthys crocea stem cell complete medium is changed every two days; and
(2) a co-differentiation: when the muscle satellite cells and the adipose-derived stem cells from the Larimichthys crocea co-cultivated in the step (1) grow to a density of 90% or more, removing the Larimichthys crocea stem cell complete medium, adding a Larimichthys crocea adipogenic differentiation medium to allow a differentiation for 7 d to 21 d, wherein the Larimichthys crocea adipogenic differentiation medium is changed every other day, and adding a Larimichthys crocea myogenic differentiation medium to allow a myogenic differentiation for 4 d to 6 d, wherein the co-differentiation lasts for 11 d to 27 d in total.

### Claim 2 (depends on 1)

The method according to claim 1, wherein in the step (1), the Larimichthys crocea stem cell complete medium comprises a 90% DMEM/F12 basal medium and a 10% fetal bovine serum.

### Claim 3 (depends on 1)

The method according to claim 1, wherein in the step (2), the Larimichthys crocea adipogenic differentiation medium comprises a 90% DMEM/F12 basal medium and a 10% fetal bovine serum, and further comprises the following adipogenic induction factors: insulin at a concentration of 1 mg/L to 10 mg/L, dexamethasone at a concentration of 0.5 μmol/L to 5 μmol/L, rosiglitazone at a concentration of 2 μmol/L to 20 μmol/L, indomethacin at a concentration of 10 μmol/L to 100 μmol/L, 3-isobutyl-1-methylxanthine at a concentration of 0.05 mmol/L to 1 mmol/L, arachidonic acid at a concentration of 1 μg/mL to 20 μg/mL, cholesterol at a concentration of 110 μg/L to 2,200 μg/L, tocopheryl acetate at a concentration of 35 μg/L to 700 μg/L, oleic acid at a concentration of 5 μg/L to 100 μg/L, linoleic acid at a concentration of 5 μg/L to 100 μg/L, palmitic acid at a concentration of 5 μg/L to 100 μg/L, stearic acid at a concentration of 5 μg/L to 100 μg/L, linolenic acid at a concentration of 5 μg/L to 100 μg/L, and myristic acid at a concentration of 5 μg/L to 100 μg/L.

### Claim 4 (depends on 1)

The method according to claim 1, wherein in the step (2), the Larimichthys crocea myogenic differentiation medium comprises a 98% DMEM/F12 basal medium and a 2% horse serum, and further comprises the following myogenic induction factor: vitamin D at a concentration of 10 ng/mL to 300 ng/mL.

### Claim 5 (depends on 1)

The method according to claim 1, wherein in the Larimichthys crocea stem cell complete medium and the Larimichthys crocea adipogenic differentiation medium, antibiotics are further added.

### Claim 6 (depends on 1)

The method according to claim 1, wherein in the step (1), a process for isolating the muscle satellite cells and the adipose-derived stem cells from the Larimichthys crocea comprises the following steps:
(0-1) collecting a muscle tissue or an adipose tissue from the Larimichthys crocea, cutting the muscle tissue or the adipose tissue into pieces, and adding a digestion solution to allow a digestion for 0.2 h to 3 h to obtain a digested tissue mixed solution; adding a washing solution to the digested tissue mixed solution for a washing, filtering to obtain a first cell suspension, and centrifuging the first cell suspension at 800 rpm/min to 2,000 rpm/min for 5 min to 10 min to collect first centrifuged cells; and adding the washing solution to the first centrifuged cells for the washing, and centrifuging to collect second centrifuged cells;
(0-2) if visible red blood cells are observed in a cell pellet produced after a centrifugation, conducting a red blood cell lysis; and if no visible red blood cells are observed in the cell pellet produced after the centrifugation, directly proceeding to a next step; and
(0-3) resuspending the second centrifuged cells with the Larimichthys crocea stem cell complete medium to obtain a second cell suspension, inoculating the second cell suspension in a 6-well cell culture plate, and cultivating for 3 h to obtain a cell solution; transferring the cell solution to a new well, supplementing the Larimichthys crocea stem cell complete medium to 3 mL, and cultivating at 28° C.; and when a cell confluency reaches 85% to 90%, conducting a passage.

### Claim 7 (depends on 6)

The method according to claim 6, wherein in the step (0-1), a mass-to-volume ratio of the muscle tissue or the adipose tissue to the digestion solution is 1:1 to 1:10, a mass-to-volume ratio of the muscle tissue or the adipose tissue to the washing solution is 1:1 to 1:10, a formula of the digestion solution comprises 0.1 mg/mL to 1 mg/mL of collagenase type I and 0.05 mg/mL to 1 mg/mL of trypsin, and the washing solution is a D-hanks solution.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the passage is conducted as follows: removing an old medium, adding 1 mL to 3 mL of phosphate-buffered saline (PBS) to wash cells from the 6-well cell culture plate 1 to 2 times to remove a residual serum, and adding 100 μL to 300 μL of 0.25% trypsin to digest the cells from the 6-well cell culture plate; when the cells from the 6-well cell culture plate are observed under a microscope to become spherical and most of the cells from the 6-well cell culture plate fall off after a tapping, adding 1 mL of the Larimichthys crocea stem cell complete medium to stop the digestion to obtain a third cell suspension, transferring the third cell suspension into a 2 mL Eppendorf tube and centrifuging the third cell suspension at 1200 rpm for 5 min, adding 2 mL of the Larimichthys crocea stem cell complete medium to resuspend cells after the third cell suspension is centrifuged, and gently pipetting up and down several times to obtain a fourth cell suspension; dispensing the fourth cell suspension into T25 flasks according to a volume ratio of 1:2 or 1:3, and supplementing a medium system in each of the T25 flasks to 5 mL; and sealing and labeling the T25 flasks, and incubating in the biochemical incubator at 28° C.
